Prognosis - What does the clinician associate with this notion?

Statistics in Medicine

Volumn 19, Issue 4, 2000, Pages 425-430

  Windeler, Jürgen ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MDS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

CANCER CLASSIFICATION; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; COLORECTAL CANCER; CONFERENCE PAPER; HUMAN; MEDICAL DECISION MAKING; PHYSICIAN; PROGNOSIS; STATISTICAL MODEL;

DECISION SUPPORT TECHNIQUES; FORECASTING; HUMANS; PHYSICIANS; PROGNOSIS; TERMINOLOGY;

EID: 0034728361     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(20000229)19:4<425::AID-SIM347>3.0.CO;2-J     Document Type: Conference Paper

References (10)

1. Hilden J. Speaking of prognosis. Revista Medico-cshirurgicala 1990; 94:171-176.
2. Hilden J, Habbema JDF. Prognosis in medicine: an analysis of its meaning and role. Theoretical Medicine 1987; 8:349-365.
3. Larvin M, McMahon MJ. Apache - II score for assessment and monitoring of acute pancreatitis. Lancet 1989; II:201-204.
4. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. New England Journal of Medicine 1997; 336:243-250.
5. Wyatt JC, Altman DG. Commentary: Prognostic models: clinically useful or quickly forgotten? British Medical Journal 1995; 311:1539-1541.
6. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. British Journal of Cancer 1994; 69:979-985.
7. Byrne MJ, Gebski V, Forbes J, Tattersall MH, Simes RJ, Coates AS, Dewar J, Lunn M, Flower C, Gill PG, Stewart J. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Journal of Clinical Oncology 1997; 15:3141-3148.
8. Cooper GS, Bellamy P, Dawson NV, Desbiens N, Fulkerson WJ, Goldman L, Quinn LM, Speroff T, Landefeld CS. A prognostic model for patients with end-stage liver disease. Gastroenterology 1997; 113:1278-1288.
9. Köbberling J, Trampisch HJ, Windeler J (eds). Memorandum for the evaluation of diagnostic measures. Journal of Clinical Chemistry and Clinical Biochemistry 1990; 28:873-879.
10. Hasford J, Pfirrmann M, Hehlmann R, Allan NC, Baccarani M, Kluin-Nelemanns JC, Alimena G, Steegmann JL, Ansari H. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alpha. Journal of National Cancer Institute 1998; 90:850-858.